Women In Health IT
Shannon Kennedy, healthcare innovation, technology chair and senior executive fellow at The Digital Economist, previews her upcoming HIMSS26 immersive workshop.
Remote Patient Monitoring
Rural Americans are nearly three times more likely to develop chronic kidney disease than those in urban areas. Dr. Sharica Brookins has proven that, with telehealth and RPM, 100% virtual kidney care is not only possible, but essential.
Healthcare IT security expert Danielle Morrison explains how IT outage recovery, downtime and disruption costs some independent and senior care providers "tens of thousands of dollars per minute" and compromises patient safety and care quality.
Health tech has the ability to address unmet needs, though careful, thoughtful adoption is required to ensure safe, systemwide impact, says Esther Kim, head of emerging technologies at Mass General Brigham.
Success Stories & ROI
After careful research, the hospital changed its practices – and was able to eliminate nearly 500 metric tons of carbon dioxide emissions last year alone. A pediatric anesthesiologist describes how the HIMSS EMRAM Stage 7 facility achieved this feat.
The partnership will allow Mira's hormone test results to be compared with Oura Ring data on sleep, temperature and readiness, enabling trend tracking.
Sustaining Rural Health
Improving accountability and streamlining technical complexities are key to improving cybersecurity postures now at small- to medium-sized hospitals, says Jackie Mattingly of Clearwater.
Success Stories & ROI
The network covers patients within an area ranging 53,000 square miles. Access to essential mental and behavioral health services has skyrocketed, with patients getting care in hours not weeks, two telehealth leaders report.
Debra Beauregard, director of medical intelligence and innovation at San Diego-based Rady Children's Health, joins MobiHealthNews to discuss partnering with digital health companies.
The pharma giant alleges that Hims & Hers is infringing its patents and misleading consumers by selling unsafe, unapproved compounded versions of its semaglutide drugs.